Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
405,051
-
Share change
-
-251,048
-
Total reported value
-
$1,385,659
-
Price per share
-
$3.42
-
Number of holders
-
16
-
Value change
-
-$649,847
-
Number of buys
-
11
-
Number of sells
-
5
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2023
As of 30 Sep 2023 Immix Biopharma, Inc. - Common Stock (IMMX) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 405,051 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Koshinski Asset Management, Inc., STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, Imprint Wealth LLC, Moss Adams Wealth Advisors LLC, BlackRock Inc., InterOcean Capital Group, LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P..
This table shows 16 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.